ArticleJournal of medical Internet research2025
Large Language Model–Assisted Risk-of-Bias Assessment in Randomized Controlled Trials Using the Revised Risk-of-Bias Tool: Evaluation Study.
Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Integration of large language models and evidence-based Chinese medicine: A scoping review.Integrative medicine research · 2026Review
- Applications of Large Language Models in Medical Research: From Systematic Reviews to Clinical Studies.Bioengineering (Basel, Switzerland) · 2026Review
- Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study.Scientific reports · 2026Article
- How large language models can help us write a systematic review.Intensive care medicine · 2026Article
- Leveraging Large Language Models for Early Detection of Anomaly Work Injury Cases: Data-Driven Approach to Rehabilitation Efficiency.JMIR rehabilitation and assistive technologies · 2026Article
- Evaluating large language model performance in Risk of Bias assessments: A cross-sectional validation study.PloS one · 2026Article
- From Research to Practice in Days, not Decades: Why Leaders Must Act now.Journal of medical systems · 2025Article
- Correction: Large Language Model-Assisted Risk-of-Bias Assessment in Randomized Controlled Trials Using the Revised Risk-of-Bias Tool: Evaluation Study.Journal of medical Internet research · 2025Article
- Article
Corrections and comments
- Erratum issued
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe revised Risk-of-Bias tool (RoB2) overcomes the limitations of its predecessor but introduces new implementation challenges. Studies demonstrate low interrater reliability and substantial time requirements for RoB2 implementation. Large language models (LLMs) may assist in RoB2 implementation, although their effectiveness remains uncertain.
objectiveThis study aims to evaluate the accuracy of LLMs in RoB2 assessments to explore their potential as research assistants for bias evaluation.
methodsWe systematically searched the Cochrane Library (through October 2023) for reviews using RoB2, categorized by interest in adhering or assignment. From 86 eligible reviews of randomized controlled trials (covering 1399 RCTs), we randomly selected 46 RCTs (23 per category). In addition, 3 experienced reviewers independently assessed all 46 RCTs using RoB2, recording assessment time for each trial. Reviewer judgments were reconciled through consensus. Furthermore, 6 RCTs (3 from each category) were randomly selected for prompt development and optimization. The remaining 40 trials established the internal validation standard, while Cochrane Reviews judgments served as external validation. Primary outcomes were extracted as reported in corresponding Cochrane Reviews. We calculated accuracy rates, Cohen κ, and time differentials.
resultsWe identified significant differences between Cochrane and reviewer judgments, particularly in domains 1, 4, and 5, likely due to different standards in assessing randomization and blinding. Among the 20 articles focusing on adhering, 18 Cochrane Reviews and 19 reviewer judgments classified them as "High risk," while assignment-focused RCTs showed more heterogeneous risk distribution. Compared with Cochrane Reviews, LLMs demonstrated accuracy rates of 57.5% and 70% for overall (assignment) and overall (adhering), respectively. When compared with reviewer judgments, LLMs' accuracy rates were 65% and 70% for these domains. The average accuracy rates for the remaining 6 domains were 65.2% (95% CI 57.6-72.7) against Cochrane Reviews and 74.2% (95% CI 64.7-83.9) against reviewers. At the signaling question level, LLMs achieved 83.2% average accuracy (95% CI 77.5-88.9), with accuracy exceeding 70% for most questions except 2.4 (assignment), 2.5 (assignment), 3.3, and 3.4. When domain judgments were derived from LLM-generated signaling questions using the RoB2 algorithm rather than direct LLM domain judgments, accuracy improved substantially for Domain 2 (adhering; 55-95) and overall (adhering; 70-90). LLMs demonstrated high consistency between iterations (average 85.2%, 95% CI 85.15-88.79) and completed assessments in 1.9 minutes versus 31.5 minutes for human reviewers (mean difference 29.6, 95% CI 25.6-33.6 minutes).
conclusionsLLMs achieved commendable accuracy when guided by structured prompts, particularly through processing methodological details through structured reasoning. While not replacing human assessment, LLMs demonstrate strong potential for assisting RoB2 evaluations. Larger studies with improved prompting could enhance performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.